Media & News

June 7 2010
Karyopharm Therapeutics has signed an agreement with O2h, a discovery services company, in order to further its lead small molecule program toward the nomination of a development candidate.
Read more >.

April 30 2009
The crystal structure of CRM1 in complex with a substrate called snurportin 1 was solved by our collaborator Prof. Yuh Min Chook (University of Texas Southwestern).